CA2336261A1 - Cyclin e2 genes and proteins - Google Patents

Cyclin e2 genes and proteins Download PDF

Info

Publication number
CA2336261A1
CA2336261A1 CA002336261A CA2336261A CA2336261A1 CA 2336261 A1 CA2336261 A1 CA 2336261A1 CA 002336261 A CA002336261 A CA 002336261A CA 2336261 A CA2336261 A CA 2336261A CA 2336261 A1 CA2336261 A1 CA 2336261A1
Authority
CA
Canada
Prior art keywords
cyclin
genes
proteins
polypeptides
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002336261A
Other languages
French (fr)
Other versions
CA2336261C (en
Inventor
Steven Roy Coats
Michael Brian Bass
Murray O. Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc.
Steven Roy Coats
Michael Brian Bass
Murray O. Robinson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc., Steven Roy Coats, Michael Brian Bass, Murray O. Robinson filed Critical Amgen Inc.
Publication of CA2336261A1 publication Critical patent/CA2336261A1/en
Application granted granted Critical
Publication of CA2336261C publication Critical patent/CA2336261C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Abstract

Disclosed are nucleic acid molecules encoding cyclin E2 polypeptides. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
CA002336261A 1998-06-05 1999-01-28 Cyclin e2 genes and proteins Expired - Fee Related CA2336261C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/092,770 1998-06-05
US09/092,770 US5973119A (en) 1998-06-05 1998-06-05 Cyclin E genes and proteins
PCT/US1999/001737 WO1999063089A1 (en) 1998-06-05 1999-01-28 Cyclin e2 genes and proteins

Publications (2)

Publication Number Publication Date
CA2336261A1 true CA2336261A1 (en) 1999-12-09
CA2336261C CA2336261C (en) 2008-05-13

Family

ID=22235079

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002336261A Expired - Fee Related CA2336261C (en) 1998-06-05 1999-01-28 Cyclin e2 genes and proteins

Country Status (10)

Country Link
US (4) US5973119A (en)
EP (1) EP1082423B1 (en)
JP (1) JP2002517196A (en)
AT (1) ATE310085T1 (en)
AU (1) AU752358B2 (en)
CA (1) CA2336261C (en)
DE (1) DE69928395T2 (en)
DK (1) DK1082423T3 (en)
ES (1) ES2252928T3 (en)
WO (1) WO1999063089A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933376B2 (en) 1998-09-23 2005-08-23 Pioneer Hi-Bred International, Inc. Cell cycle polynucleotides, polypeptides and uses thereof
US20050076404A1 (en) * 1999-02-12 2005-04-07 Pioneer Hi-Bred International, Inc. Cell cycle polynucleotides, polypeptides and uses thereof
US20030092890A1 (en) * 1999-07-28 2003-05-15 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1255851A4 (en) * 2000-03-08 2004-03-31 Harvey J Kliman Methods of diagnosing and monitoring endometrial glandular development
EP1435776A4 (en) 2001-09-24 2006-01-25 Univ Pittsburgh Anticancer vaccine and diganostic methods and reagents
CA2526490C (en) * 2003-05-19 2014-03-04 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
WO2007044033A2 (en) 2004-12-07 2007-04-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
EP1965814A4 (en) * 2005-09-26 2012-01-11 Univ Columbia Side population cells in cardiac repair
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CA2821426A1 (en) * 2005-12-22 2007-07-05 Abbott Laboratories Methods and marker combinations for screening for predisposition to lung cancer
US20080260725A1 (en) * 2007-03-29 2008-10-23 Ulhas Naik Tag and target delivery system
WO2010011994A2 (en) 2008-07-25 2010-01-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Polypeptides and uses thereof
EP2309273B1 (en) * 2009-09-16 2016-05-18 ZEILLINGER, Robert Novel tumor marker determination
CN112625133A (en) * 2021-01-14 2021-04-09 山西农业大学 CDK2 nano antibody and application thereof
CN116217722B (en) * 2023-03-22 2023-09-15 广东省第二人民医院（广东省卫生应急医院） Nanometer antibody of anti-cyclin E protein, encoding gene and application

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3015417A1 (en) * 1980-04-22 1981-10-29 Basf Ag, 6700 Ludwigshafen METHOD FOR PRODUCING MOLDED PARTS FROM UNSATURATED POLYESTER RESINS
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
US4615885A (en) * 1983-11-01 1986-10-07 Terumo Kabushiki Kaisha Pharmaceutical composition containing urokinase
EP0154316B1 (en) * 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
CA1310924C (en) * 1986-04-24 1992-12-01 Francis P. Mccormick Infective drug delivery system
US4970154A (en) * 1987-10-09 1990-11-13 Baylor College Of Medicine Method for inserting foreign genes into cells using pulsed radiofrequency
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5106627A (en) * 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5672344A (en) * 1987-12-30 1997-09-30 The Regents Of The University Of Michigan Viral-mediated gene transfer system
US5011472A (en) * 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
CA2006596C (en) * 1988-12-22 2000-09-05 Rika Ishikawa Chemically-modified g-csf
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5676954A (en) * 1989-11-03 1997-10-14 Vanderbilt University Method of in vivo delivery of functioning foreign genes
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
ATE273386T1 (en) * 1991-09-20 2004-08-15 Hutchinson Fred Cancer Res HUMAN CYCLIN E
US5489743A (en) * 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
US6664107B1 (en) * 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
CA2161015A1 (en) * 1993-05-26 1994-12-08 Tak Wah Mak Transgenic mammals lacking expression of particular cd45 isoforms
ES2178654T3 (en) * 1993-08-12 2003-01-01 Neurotech Sa IMMONO-ISOLATED BIOCOMPATIBLE CAPSULES CONTAINING GENETICALLY ALTERED CELLS FOR THE SUPPLY OF BIOLOGICALLY ACTIVE MOLECULES.
US5631236A (en) * 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
US5688665A (en) * 1994-01-07 1997-11-18 Fred Hutchinson Cancer Research Center Isolated nucleic acid molecules encoding the p27 KIP-1 protein
US6635450B1 (en) * 1994-07-15 2003-10-21 Fred Hutchinson Institute For Cancer Research Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agents
US5484720A (en) * 1994-09-08 1996-01-16 Genentech, Inc. Methods for calcium phosphate transfection
AU705035B2 (en) * 1995-06-07 1999-05-13 Baylor College Of Medicine Nucleic acid transporters for delivery of nucleic acids into a cell
CA2230795A1 (en) * 1995-09-07 1997-03-13 Khandan Keyomarsi Cyclin e variants and use thereof
US5679559A (en) * 1996-07-03 1997-10-21 University Of Utah Research Foundation Cationic polymer and lipoprotein-containing system for gene delivery
WO1998003649A1 (en) * 1996-07-24 1998-01-29 Pharmacia & Upjohn Company Constructs and complexes of cyclin e

Also Published As

Publication number Publication date
US7455963B2 (en) 2008-11-25
CA2336261C (en) 2008-05-13
WO1999063089A1 (en) 1999-12-09
EP1082423B1 (en) 2005-11-16
DE69928395D1 (en) 2005-12-22
DE69928395T2 (en) 2006-06-01
AU752358B2 (en) 2002-09-19
ES2252928T3 (en) 2006-05-16
US20030078370A1 (en) 2003-04-24
JP2002517196A (en) 2002-06-18
US6943238B2 (en) 2005-09-13
US5973119A (en) 1999-10-26
DK1082423T3 (en) 2006-02-13
EP1082423A1 (en) 2001-03-14
AU2475499A (en) 1999-12-20
ATE310085T1 (en) 2005-12-15
US6165753A (en) 2000-12-26
US20050282150A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
WO1998021343A8 (en) Genes encoding telomerase proteins
WO2000018914A3 (en) Novel dkr polypeptides
CA2258502A1 (en) Modified factor viii
HK1040401A1 (en) Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
AU3274995A (en) Fibrin-binding peptides, dna coding therefor and uses thereof
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
CA2253238A1 (en) Novel agouti-related gene
CA2295999A1 (en) Nik proteins, nucleic acids and methods
CA2336261A1 (en) Cyclin e2 genes and proteins
EP0804609A4 (en) NOVEL p53 RESPONSE GENES
WO2002062999A3 (en) Proteins and nucleic acids encoding same
ZA9710288B (en) Novel genes encoding telomerase proteins.
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO2002046409A3 (en) Proteins and nucleic acids encoding same
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
WO1996007739A3 (en) Interleukin-1 type 3 receptors
AU3866197A (en) Novel DNA and process for preparing protein using the DNA
AU3354499A (en) Human mekk proteins, corresponding nucleic acid molecules, and uses therefor
EP1001964A4 (en) Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
WO2001064837A3 (en) β NETRIN AND USES THEREOF
AU7147898A (en) (dirofilaria) and (brugia) ankyrin proteins, nucleic acid molecules, and uses thereof
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed